Inactivation of Macrophage Scavenger Receptor Class B Type I Promotes Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice

Background—Scavenger receptor class B type I (SR-BI) is expressed in macrophages, where it has been proposed to facilitate cholesterol efflux. However, direct evidence that the expression of macrophage SR-BI is protective against atherosclerosis is lacking. In this study, we examined the in vivo role of macrophage SR-BI in atherosclerotic lesion development in the apolipoprotein (apo) E–deficient mouse model. Methods and Results—ApoE-deficient mice with (n=16) or without (n=15) expression of macrophage SR-BI were created by transplanting lethally irradiated apoE-deficient mice with bone marrow cells collected from SR-BI−/− apoE−/− mice or SR-BI+/+ apoE−/− mice. The recipient mice were fed a chow diet for 12 weeks after transplantation for analysis of atherosclerosis. Quantification of macrophage SR-BI mRNA by real-time reverse transcription–polymerase chain reaction indicated successful engraftment of donor bone marrow and inactivation of macrophage SR-BI in recipient mice reconstituted with SR-BI−/− apoE−/− bone marrow. There were no significant differences in plasma lipid levels, lipoprotein distributions, and HDL subpopulations between the 2 groups. Analysis of the proximal aorta demonstrated an 86% increase in mean atherosclerotic lesion area in SR-BI−/− apoE−/− → apoE−/− mice compared with SR-BI+/+ apoE−/− → apoE−/− mice (109.50±18.08 versus 58.75±9.58×103 &mgr;m2; mean±SEM, P =0.017). No difference in cholesterol efflux from SR-BI+/+ apoE−/− or SR-BI−/− apoE−/− macrophages to HDL or apoA-I discs was detected. Conclusions—Expression of macrophage SR-BI protects mice against atherosclerotic lesion development in apoE-deficient mice in vivo without influencing plasma lipids, HDL subpopulations, or cholesterol efflux. Thus, macrophage SR-BI plays an antiatherogenic role in vivo, providing a new therapeutic target for the design of strategies to prevent and treat atherosclerosis.

[1]  Scott D Covey,et al.  Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[2]  T. V. van Berkel,et al.  Differential Effects of Scavenger Receptor BI Deficiency on Lipid Metabolism in Cells of the Arterial Wall and in the Liver* , 2003, Journal of Biological Chemistry.

[3]  M. Linton,et al.  Reverse Transcriptase-Polymerase Chain Reaction , 2020, Definitions.

[4]  M. Connelly,et al.  Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. , 2002, Biochemistry.

[5]  A. Daugherty,et al.  Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice DOI 10.1194/jlr.M200026-JLR200 , 2002, Journal of Lipid Research.

[6]  M. Krieger,et al.  Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and Premature Death in Apolipoprotein E-Deficient Mice , 2002, Circulation research.

[7]  Seth M. Klein,et al.  Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. , 2001, Journal of lipid research.

[8]  M. Krieger,et al.  Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. , 2001, The Journal of clinical investigation.

[9]  A. Rigotti,et al.  Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. , 2001, Journal of lipid research.

[10]  O. Francone,et al.  Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001, The Journal of clinical investigation.

[11]  Mayur B. Patel,et al.  Macrophage Lipoprotein Lipase Promotes Foam Cell Formation and Atherosclerosis in Low Density Lipoprotein Receptor-deficient Mice* , 2000, The Journal of Biological Chemistry.

[12]  E. Rubin,et al.  Relationship between Expression Levels and Atherogenesis in Scavenger Receptor Class B, Type I Transgenics* , 2000, The Journal of Biological Chemistry.

[13]  A. Tedgui,et al.  CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.

[14]  T. Arai,et al.  Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  D. Rader,et al.  Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Connelly,et al.  Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. , 2000, Biochemistry.

[17]  A. Rigotti,et al.  Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Krieger.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.

[19]  E. Rubin,et al.  Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice* , 1999, The Journal of Biological Chemistry.

[20]  A. Tall,et al.  Decreased Atherosclerosis in Heterozygous Low Density Lipoprotein Receptor-deficient Mice Expressing the Scavenger Receptor BI Transgene* , 1999, The Journal of Biological Chemistry.

[21]  B. Asztalos,et al.  Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I. , 1998, Journal of lipid research.

[22]  A. Tall,et al.  Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. V. van Berkel,et al.  In Vivo Regulation of Scavenger Receptor BI and the Selective Uptake of High Density Lipoprotein Cholesteryl Esters in Rat Liver Parenchymal and Kupffer Cells* , 1998, The Journal of Biological Chemistry.

[24]  A. Rigotti,et al.  A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Asztalos,et al.  Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Yong Ji,et al.  Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* , 1997, The Journal of Biological Chemistry.

[27]  E. Edelman,et al.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.

[28]  W. J. Johnson,et al.  Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. , 1995, Biochemistry.

[29]  S. Fazio,et al.  Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.

[30]  D. Sparks,et al.  The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior. , 1992, The Journal of biological chemistry.

[31]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[32]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[33]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[35]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[36]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.